However, some other peptides, including thymosin β4 (TMSB4X), CD99, and Na–K-ATPase γ-subunit (FXYD2), are not currently known to be involved in AKI pathophysiology and may represent good candidates for further exploration of their role in AKI. The gene discussed is FXYD2; the disease is acute kidney injury.